Senior Partner with McKinsey, based in China for close to 20 years. I guide Multinationals across sectors to navigate the "China imperative", and the need to reconfigure for opportunity and risk.
Another sizable licensing deal East-West. Interestingly, the licensor is not a big pharma. Showing that significant value creation could be captured by small/mid-size Western players. But also how crowded the space could become. #biotech #innovation